TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ALRA

CardiovascularGastroenterologyNeurology
Generics

ALRA is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Neurology.

1971
Since
17
Drugs
-
Trials
31
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

ACETAZOLAMIDE 2026-01-12
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2026-01-08
Labeling
ACETAZOLAMIDE 2025-11-25
Manufacturing (CMC)
DIPHENHYDRAMINE HYDROCHLORIDE 2025-11-14
ACETAZOLAMIDE 2025-09-16
Labeling
ACETAZOLAMIDE 2025-09-16
Labeling
DIPHENHYDRAMINE HYDROCHLORIDE 2025-08-22
DIPHENHYDRAMINE HYDROCHLORIDE 2025-06-24
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 40%
2 drugs
Gastroenterology 20%
1 drugs
Neurology 20%
1 drugs
Ophthalmology 20%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

BAUSCH specialty
Ophthalmology, Cardiovascular, Gastroenterology
Novartis big-pharma
Cardiovascular, Ophthalmology
VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology, Neurology
UPJOHN big-pharma
Neurology, Cardiovascular, Ophthalmology
WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology